Melanoma/Skin Cancers Information

Return to Previous Page

FDA Approves Mekinist in Combination with Tafinlar for Advanced Melanoma

The U.S. Food and Drug Administration has approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (late-stage).

Read More


FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer

The U.S. Food and Drug Administration has approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

Read More


Former Pro Football Coach Bill Cowher Tells Men “No Excuses” When it Comes to Getting Screened for Melanoma

A new survey shows that when it comes to getting screened for skin cancer, one in six men avoid going for fear of the results they will receive. To address this lack of action and empower men to take an active role in their skin health, former professional football coach Bill Cowher is teaming up for a second time with leading melanoma advocacy groups and Bristol-Myers Squibb Company on the educational campaign Melanoma Exposed: Screen. Protect. Know. Tell.  

Read More


Lymphoseek Approved to Help Locate Lymph Nodes in Patients with Certain Cancers

The U.S. Food and Drug Administration has approved Lymphoseek Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.

Read More


New Therapies for Treating Advanced Melanoma

While melanoma, the most serious form of skin can­cer, is highly curable when detected and treated early, the same is not true for more advanced cases of melanoma – particularly when the dis­ease has spread to lymph nodes or other areas of the body.

Read More


New Treatment Approved for Most Common Type of Skin Cancer

The U.S. Food and Drug Administration has approved Genentech’s™ (vismodegib) for the treat­ment of adults with basal cell carcinoma (the most common type of skin cancer) that has spread to other parts of the body, that has come back after surgery, or that their healthcare provider decides can­not be treated with surgery or radiation.

Read More


New Guidelines of Care for Treatment of Melanoma

Based on an extensive review of scientific literature and the recommendations of recognized melanoma experts, the American Academy of Dermatology (Academy) has released updated evidence-based guidelines for the treatment of melanoma, the deadliest form of skin cancer.

Read More


Melanoma Treatment Choices by Stage

The following are brief descriptions of the treatments most often used for each stage of melanoma.

Read More


Page 1 of 2  1 2 > 


eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine